a:3:{s:6:"_token";s:40:"KozwD3WIN52IUDRM8aNpmi0slQy7VAI5yyrXh6Tw";s:9:"_previous";a:1:{s:3:"url";s:173:"https://www.pharmafocusasia.com/news/windtree-therapeutics-and-lees-pharmaceuticals-license-istaroxime-dual-serca2a-activators-and-rostafuroxin-for-greater-chinaasia-pacific";}s:6:"_flash";a:2:{s:3:"old";a:0:{}s:3:"new";a:0:{}}}